[Federal Register Volume 73, Number 77 (Monday, April 21, 2008)]
[Notices]
[Page 21359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-8474]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Office of 
Biotechnology Activities; Recombinant DNA Research; Notice of a Meeting 
of an NIH Blue Ribbon Panel

    There will be a meeting of the NIH Blue Ribbon Panel to advise on 
the Risk Assessment of the National Emerging Infectious Diseases 
Laboratories (NEIDL) at the Boston Medical Center. The meeting will be 
held on Friday, May 2, 2008, at the National Institutes of Health, 
Building 31, Floor 6C, Conference Room 10, 31 Center Drive, Bethesda, 
Maryland 20892, from 8:30 a.m. to approximately 11:30 a.m.
    The National Research Council Committee that provided technical 
input on the NIH's Draft Supplementary Risk Assessments and Site 
Suitability Analyses for the NEIDL will participate in discussions with 
Panel members regarding the scope and design of additional studies that 
may be needed to assess risk associated with the siting and operation 
of the NEIDL.
    For further information concerning this meeting contact Ms. Laurie 
Lewallen, Advisory Committee Coordinator, Office of Biotechnology 
Activities, Office of the Director, National Institutes of Health, 6705 
Rockledge Drive, Room 750, Bethesda, MD 20892-7985, 301-496-9838, 
[email protected].
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed above in 
advance of the meeting. Any interested person may file written comments 
with the panel by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    NIH campus security procedures require that all visitor vehicles, 
including taxicabs and hotel and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one form 
of identification (for example, a government-issued photo ID, driver's 
license, or passport) and to state the purpose of their visit.
    An agenda and any additional information for the meeting will be 
posted on the agency's Web site: http://www.nih.gov/about/director/acd/index.htm.
    Background information may be obtained by contacting NIH OBA by e-
mail [email protected].

    Dated: April 14, 2008.
Amy P. Patterson,
Director, Office of Biotechnology Activities.
[FR Doc. E8-8474 Filed 4-18-08; 8:45 am]
BILLING CODE 4140-01-P